Closed-loop Vagus Nerve Stimulation (VNS) represents a profound evolution within bioelectronic medicine, transitioning from static, pre-programmed therapies to adaptive, personalised interventions.

Electric medicine, often referred to as electroceuticals or bioelectronic medicine, is rapidly emerging as a pivotal and transformative HealthTech sub-sector in 2025. This field leverages targeted electrical stimulation of the nervous system to address a wide array of chronic diseases, offering a compelling alternative to traditional pharmacological interventions.

The "string-of-pearls" mergers and acquisitions (M&A) strategy has become a pivotal approach for large biopharmaceutical and MedTech entities operating within or with significant interests in Europe.

The emergence of a healthcare-specific AI web browser represents a pivotal opportunity to establish the next billion-dollar HealthTech company.

Accelerating UK Healthcare Innovation: Analysis of the NHS 'Innovator Passports' Initiative Executive Summary The National Health Service...

The German Digital Health Act (DiGA): Strategy, Impact, Challenges and Future Direction I. Executive Summary The German Digital Health...

European HealthTech, Digital Health and Healthcare AI Exits in 2025: A Mid-Year Analysis and Outlook Executive Summary The European...

Hypothetical Acquisition of TPP by Oracle: Longitudinal Care Record and Unified Patient Data Management I. Executive Summary This report...

Quantum Health: A Strategic Analysis of Healthcare Navigation and Cost Management Leadership 1. Executive Summary Quantum Health,...

National Virtual Ward Platform for Neighbourhood Health Services: The UK's Digital Health Transformation Plans 1. Executive Summary The...

The HealthTech and Digital Health Landscape: Definitions, Ecosystem Dynamics and 10-Year Outlook to 2035 I. Executive Summary The...

NHS England has issued an urgent notification regarding the use of Ambient Voice Technology (AVT) solutions, also known as AI scribe technology, in clinical settings.

The IPO landscape for HealthTech startups in 2025 is likely to be dynamic, influenced by various factors such as market conditions, company performance and regulatory changes. While it's challenging to predict with certainty which specific companies will go public, the following six HealthTech startups have the potential to be among the IPO candidates: Omada Health, Hinge Health, Sword Health, Doctolib, Aledade, Quantum Health

HealthTech M&A multiples: Current Trends and Variables driving valuations Mid 2024 Exec Summary: The average revenue multiple for...

Exec Summary The average multiples in HealthTech M&A deals in 2024 have slightly increased compared to 2023, reflecting a more optimistic...